Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target

Yuka Tanaka1, Maho Murata1, Keiko Tanegashima1

  • 1Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka City, Fukuoka, 812-8582, Japan.

Scientific Reports
|March 8, 2022
PubMed

Insights

Nectin cell adhesion molecule 4 (NECTIN4) is highly expressed in angiosarcoma, a rare cancer. Targeting NECTIN4 shows potential for new angiosarcoma treatments, inhibiting cancer cell growth and blood vessel formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Angiosarcoma is a rare, aggressive soft tissue sarcoma with poor prognosis.
  • Current treatments for unresectable or metastatic angiosarcoma have limited efficacy.
  • Nectin cell adhesion molecule 4 (NECTIN4) is implicated in various cancers, but its role in angiosarcoma is unclear.

Purpose of the Study:

  • To investigate the expression and function of NECTIN4 in angiosarcoma.
  • To evaluate NECTIN4 as a potential therapeutic target for angiosarcoma.

Main Methods:

  • Immunohistochemistry was used to analyze NECTIN4 expression in 74 angiosarcoma tissue samples.
  • NECTIN4 expression and function were studied in human angiosarcoma cell lines.
  • Nectin cell adhesion molecule 4 (NECTIN4) knockdown and sensitivity to antibody-drug conjugates were assessed.

Main Results:

  • NECTIN4 was found to be highly expressed in angiosarcoma cells compared to normal endothelial cells.
  • Angiosarcoma cells showed sensitivity to NECTIN4-targeted antibody-drug conjugates.
  • NECTIN4 knockdown suppressed angiosarcoma cell proliferation and angiogenesis, involving Src kinase signaling.

Conclusions:

  • Nectin cell adhesion molecule 4 (NECTIN4) is a promising therapeutic target for angiosarcoma.
  • Targeted therapies against NECTIN4 may offer a novel treatment strategy for this rare cancer.
  • Further research into NECTIN4-targeted therapies is warranted for angiosarcoma treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.1K